{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:23:10Z","timestamp":1792790590439,"version":"4.5.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Vascular anomalies currently are classified according to their clinical and histological characteristics. Recent advances in molecular genetics have enabled the identification of somatic mutations in most types of vascular anomalies. The purpose of this study was to collate information regarding the genetic basis of vascular anomalies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The PubMed literature was reviewed for all citations that identified a mutation in a vascular anomaly between 1994 and 2017. Search terms included \u201cvascular anomaly,\u201d \u201cmutation,\u201d \u201cgene,\u201d \u201chemangioma,\u201d \u201cpyogenic granuloma,\u201d \u201ckaposiform hemangioendothelioma,\u201d \u201ccapillary malformation,\u201d \u201cvenous malformation,\u201d lymphatic malformation,\u201d \u201carteriovenous malformation,\u201d and \u201csyndrome.\u201d Articles that identified both germline and somatic mutations in vascular anomalies were analyzed. Mutations were categorized by type (germline or somatic), gene, signaling pathway, and cell(s) enriched for the mutation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The majority of vascular anomalies had associated mutations that commonly affected tyrosine kinase receptor signaling through the RAS or PIK3CA pathways. Mutations in\n                      <jats:italic toggle=\"yes\">PIK3CA<\/jats:italic>\n                      and G-protein\u2013coupled receptors were most frequently identified. Specific types of vascular anomalies usually were associated with a single gene. However, mutations in the same gene occasionally were found in different vascular lesions, and some anomalies had a mutation in more than one gene. Mutations were most commonly enriched in endothelial cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Identification of somatic mutations in vascular anomalies is changing the paradigm by which lesions are diagnosed and understood. Mutations and their pathways are providing potential targets for the development of novel pharmacotherapy. In the future, vascular anomalies will be managed based on clinical characteristics and molecular pathophysiology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/prs.0000000000004294","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T11:26:35Z","timestamp":1516361195000},"page":"709e-717e","source":"Crossref","is-referenced-by-count":122,"title":["Vascular Anomalies: From a Clinicohistologic to a Genetic Framework"],"prefix":"10.1097","volume":"141","author":[{"given":"Arin K.","family":"Greene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy A.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230715","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: Recommendations from the International Society for the Study of Vascular Anomalies.","volume":"136","author":"Wassef","year":"2015","journal-title":"Pediatrics"},{"key":"R2-20230715","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006534-198203000-00002","article-title":"Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics.","volume":"69","author":"Mulliken","year":"1982","journal-title":"Plast Reconstr Surg"},{"key":"R3-20230715","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","article-title":"A mosaic activating mutation in AKT1 associated with the Proteus syndrome.","volume":"365","author":"Lindhurst","year":"2011","journal-title":"N Engl J Med"},{"key":"R4-20230715","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children.","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20230715","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/lrb.2007.1018","article-title":"The placenta theory and the origin of infantile hemangioma.","volume":"5","author":"Barn\u00e9s","year":"2007","journal-title":"Lymphat Res Biol"},{"key":"R6-20230715","first-page":"2592","article-title":"Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice.","volume":"118","author":"Khan","year":"2008","journal-title":"J Clin Invest"},{"key":"R7-20230715","doi-asserted-by":"crossref","first-page":"344e","DOI":"10.1097\/01.prs.0000438458.60474.fc","article-title":"Expression of follicle-stimulating hormone receptor in vascular anomalies.","volume":"133","author":"Maclellan","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R8-20230715","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ajhg.2016.03.009","article-title":"Somatic activating mutations in GNAQ and GNA11 are associated with congenital hemangioma.","volume":"98","author":"Ayturk","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R9-20230715","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaad.2013.09.018","article-title":"Partially involuting congenital hemangiomas: A report of 8 cases and review of the literature.","volume":"70","author":"Nasseri","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R10-20230715","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ajhg.2016.06.010","article-title":"GNA14 somatic mutation causes congenital and sporadic vascular tumors by MAPK activation.","volume":"99","author":"Lim","year":"2016","journal-title":"Am J Hum Genet"},{"key":"R11-20230715","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2015.55","article-title":"Somatic activating RAS mutations cause vascular tumors including pyogenic granuloma.","volume":"135","author":"Lim","year":"2015","journal-title":"J Invest Dermatol"},{"key":"R12-20230715","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/JID.2015.376","article-title":"BRAF and RAS mutations in sporadic and secondary pyogenic granuloma.","volume":"136","author":"Groesser","year":"2016","journal-title":"J Invest Dermatol"},{"key":"R13-20230715","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.2921","article-title":"Recurrent PTPRB and PLCG1 mutations in angiosarcoma.","volume":"46","author":"Behjati","year":"2014","journal-title":"Nat Genet"},{"key":"R14-20230715","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/gcc.20886","article-title":"A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites.","volume":"50","author":"Errani","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"R15-20230715","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/hmg\/ddx081","article-title":"PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.","volume":"26","author":"Arts","year":"2017","journal-title":"Hum Mol Genet"},{"key":"R16-20230715","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.","volume":"368","author":"Shirley","year":"2013","journal-title":"N Engl J Med"},{"key":"R17-20230715","doi-asserted-by":"crossref","first-page":"77e","DOI":"10.1097\/PRS.0000000000001868","article-title":"Endothelial cells from capillary malformations are enriched for somatic GNAQ mutations.","volume":"137","author":"Couto","year":"2016","journal-title":"Plast Reconstr Surg"},{"key":"R18-20230715","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10456-016-9538-1","article-title":"A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth.","volume":"20","author":"Couto","year":"2017","journal-title":"Angiogenesis"},{"key":"R19-20230715","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jpeds.2014.12.069","article-title":"Lymphatic and other vascular malformative\/overgrowth disorders are caused by somatic mutations in PIK3CA.","volume":"166","author":"Luks","year":"2015","journal-title":"J Pediatr"},{"key":"R20-20230715","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/hmg\/7.13.2073","article-title":"Hereditary lymphedema: Evidence for linkage and genetic heterogeneity.","volume":"7","author":"Ferrell","year":"1998","journal-title":"Hum Mol Genet"},{"key":"R21-20230715","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1086\/316915","article-title":"Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.","volume":"67","author":"Fang","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R22-20230715","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1086\/303019","article-title":"Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.","volume":"67","author":"Irrthum","year":"2000","journal-title":"Am J Hum Genet"},{"key":"R23-20230715","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1086\/375614","article-title":"Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.","volume":"72","author":"Irrthum","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R24-20230715","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ng.484","article-title":"Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans.","volume":"41","author":"Alders","year":"2009","journal-title":"Nat Genet"},{"key":"R25-20230715","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000354097","article-title":"Mutations in the VEGFR3 signaling pathway explain 36% of familial lymphedema.","volume":"4","author":"Mendola","year":"2013","journal-title":"Mol Syndromol"},{"key":"R26-20230715","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI71614","article-title":"Genetics of lymphatic anomalies.","volume":"124","author":"Brouillard","year":"2014","journal-title":"J Clin Invest"},{"key":"R27-20230715","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0092-8674(00)81814-0","article-title":"Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.","volume":"87","author":"Vikkula","year":"1996","journal-title":"Cell"},{"key":"R28-20230715","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ng.272","article-title":"Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations.","volume":"41","author":"Limaye","year":"2009","journal-title":"Nat Genet"},{"key":"R29-20230715","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000348327","article-title":"Variable somatic TIE2 mutations in half of sporadic venous malformations.","volume":"4","author":"Soblet","year":"2013","journal-title":"Mol Syndromol"},{"key":"R30-20230715","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.ajhg.2015.11.011","article-title":"Somatic activating PIK3CA mutations cause venous malformation.","volume":"97","author":"Limaye","year":"2015","journal-title":"Am J Hum Genet"},{"key":"R31-20230715","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ajhg.2015.01.007","article-title":"A somatic MAP3K3 mutation is associated with verrucous venous malformation.","volume":"96","author":"Couto","year":"2015","journal-title":"Am J Hum Genet"},{"key":"R32-20230715","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jid.2016.07.034","article-title":"Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations.","volume":"137","author":"Soblet","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R33-20230715","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/339492","article-title":"Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations (\u201cglomangiomas\u201d).","volume":"70","author":"Brouillard","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R34-20230715","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/13815","article-title":"Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas.","volume":"23","author":"Laberge-le Couteulx","year":"1999","journal-title":"Nat Genet"},{"key":"R35-20230715","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1086\/380314","article-title":"Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.","volume":"73","author":"Liquori","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R36-20230715","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1086\/426952","article-title":"Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations.","volume":"76","author":"Bergametti","year":"2005","journal-title":"Am J Hum Genet"},{"key":"R37-20230715","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","article-title":"Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation.","volume":"100","author":"Couto","year":"2017","journal-title":"Am J Hum Genet"},{"key":"R38-20230715","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/379793","article-title":"Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations.","volume":"73","author":"Eerola","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R39-20230715","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/humu.20746","article-title":"Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations.","volume":"29","author":"Revencu","year":"2008","journal-title":"Hum Mutat"},{"key":"R40-20230715","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng1294-345","article-title":"Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.","volume":"8","author":"McAllister","year":"1994","journal-title":"Nat Genet"},{"key":"R41-20230715","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng0696-189","article-title":"Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.","volume":"13","author":"Johnson","year":"1996","journal-title":"Nat Genet"},{"key":"R42-20230715","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0140-6736(04)15732-2","article-title":"A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4).","volume":"363","author":"Gallione","year":"2004","journal-title":"Lancet"},{"key":"R43-20230715","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ajhg.2013.07.004","article-title":"BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia.","volume":"93","author":"Wooderchak-Donahue","year":"2013","journal-title":"Am J Hum Genet"},{"key":"R44-20230715","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/ncb3534","article-title":"Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling.","volume":"19","author":"Jin","year":"2017","journal-title":"Nat Cell Biol"},{"key":"R45-20230715","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ng0596-114","article-title":"Localization of the gene for Cowden disease to chromosome 10q22-23.","volume":"13","author":"Nelen","year":"1996","journal-title":"Nat Genet"},{"key":"R46-20230715","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/hmg\/8.8.1461","article-title":"PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.","volume":"8","author":"Marsh","year":"1999","journal-title":"Hum Mol Genet"},{"key":"R47-20230715","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/jmg.2007.048934","article-title":"The spectrum of vascular anomalies in patients with PTEN mutations: Implications for diagnosis and management.","volume":"44","author":"Tan","year":"2007","journal-title":"J Med Genet"},{"key":"R48-20230715","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ajhg.2012.05.006","article-title":"Somatic mosaic activating mutations in PIK3CA cause CLOVES syndrome.","volume":"90","author":"Kurek","year":"2012","journal-title":"Am J Hum Genet"},{"key":"R49-20230715","doi-asserted-by":"crossref","first-page":"12e","DOI":"10.1097\/01.prs.0000436822.26709.7c","article-title":"PIK3CA activating mutations in facial infiltrating lipomatosis.","volume":"133","author":"Maclellan","year":"2014","journal-title":"Plast Reconstr Surg"},{"key":"R50-20230715","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/pr.2017.155","article-title":"Somatic PIK3CA mutations are present in multiple tissues of facial infiltrating lipomatosis.","volume":"82","author":"Couto","year":"2017","journal-title":"Pediatr Res"},{"key":"R51-20230715","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/ng.994","article-title":"Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2.","volume":"43","author":"Amary","year":"2011","journal-title":"Nat Genet"},{"key":"R52-20230715","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ajmg.c.31361","article-title":"Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP.","volume":"163","author":"Mirzaa","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R53-20230715","doi-asserted-by":"crossref","first-page":"a011189","DOI":"10.1101\/cshperspect.a011189","article-title":"PI3K-PKB\/Akt pathway.","volume":"4","author":"Hemmings","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R54-20230715","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrc4000","article-title":"MEK1 and MEK2 inhibitors and cancer therapy: The long and winding road.","volume":"15","author":"Caunt","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"R55-20230715","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1126\/science.1124642","article-title":"Germline mutations in genes within the MAPK pathway cause cardio-facio-cutaneous syndrome.","volume":"311","author":"Rodriguez-Viciana","year":"2006","journal-title":"Science"},{"key":"R56-20230715","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.1026","article-title":"Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma.","volume":"44","author":"Nikolaev","year":"2011","journal-title":"Nat Genet"},{"key":"R57-20230715","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood-2014-05-577825","article-title":"Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.","volume":"124","author":"Chakraborty","year":"2014","journal-title":"Blood"},{"key":"R58-20230715","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1078-0432.CCR-14-2124","article-title":"MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking.","volume":"21","author":"Arcila","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R59-20230715","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.","volume":"2","author":"Druker","year":"1996","journal-title":"Nat Med"},{"key":"R60-20230715","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluation.","volume":"167","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet A"}],"container-title":["Plastic &amp; Reconstructive Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006534-201805000-00034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T01:10:52Z","timestamp":1689383452000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006534-201805000-00034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/prs.0000000000004294","relation":{},"ISSN":["0032-1052"],"issn-type":[{"value":"0032-1052","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}